QQQ   294.07 (+0.24%)
AAPL   148.32 (+0.20%)
MSFT   254.00 (-0.45%)
META   118.57 (+0.40%)
GOOGL   101.03 (+0.04%)
AMZN   96.93 (+0.40%)
TSLA   197.51 (+1.44%)
NVDA   170.20 (+0.57%)
NIO   12.61 (-1.33%)
BABA   85.29 (-2.59%)
AMD   78.17 (+0.70%)
T   19.25 (-0.16%)
MU   57.66 (+0.02%)
CGC   3.70 (+2.21%)
F   13.98 (+0.58%)
DIS   98.15 (+0.29%)
AMC   7.23 (+0.00%)
PYPL   78.90 (+0.62%)
PFE   50.10 (-0.06%)
NFLX   304.57 (-0.31%)
QQQ   294.07 (+0.24%)
AAPL   148.32 (+0.20%)
MSFT   254.00 (-0.45%)
META   118.57 (+0.40%)
GOOGL   101.03 (+0.04%)
AMZN   96.93 (+0.40%)
TSLA   197.51 (+1.44%)
NVDA   170.20 (+0.57%)
NIO   12.61 (-1.33%)
BABA   85.29 (-2.59%)
AMD   78.17 (+0.70%)
T   19.25 (-0.16%)
MU   57.66 (+0.02%)
CGC   3.70 (+2.21%)
F   13.98 (+0.58%)
DIS   98.15 (+0.29%)
AMC   7.23 (+0.00%)
PYPL   78.90 (+0.62%)
PFE   50.10 (-0.06%)
NFLX   304.57 (-0.31%)
QQQ   294.07 (+0.24%)
AAPL   148.32 (+0.20%)
MSFT   254.00 (-0.45%)
META   118.57 (+0.40%)
GOOGL   101.03 (+0.04%)
AMZN   96.93 (+0.40%)
TSLA   197.51 (+1.44%)
NVDA   170.20 (+0.57%)
NIO   12.61 (-1.33%)
BABA   85.29 (-2.59%)
AMD   78.17 (+0.70%)
T   19.25 (-0.16%)
MU   57.66 (+0.02%)
CGC   3.70 (+2.21%)
F   13.98 (+0.58%)
DIS   98.15 (+0.29%)
AMC   7.23 (+0.00%)
PYPL   78.90 (+0.62%)
PFE   50.10 (-0.06%)
NFLX   304.57 (-0.31%)
QQQ   294.07 (+0.24%)
AAPL   148.32 (+0.20%)
MSFT   254.00 (-0.45%)
META   118.57 (+0.40%)
GOOGL   101.03 (+0.04%)
AMZN   96.93 (+0.40%)
TSLA   197.51 (+1.44%)
NVDA   170.20 (+0.57%)
NIO   12.61 (-1.33%)
BABA   85.29 (-2.59%)
AMD   78.17 (+0.70%)
T   19.25 (-0.16%)
MU   57.66 (+0.02%)
CGC   3.70 (+2.21%)
F   13.98 (+0.58%)
DIS   98.15 (+0.29%)
AMC   7.23 (+0.00%)
PYPL   78.90 (+0.62%)
PFE   50.10 (-0.06%)
NFLX   304.57 (-0.31%)
CVE:MPH

Medicure - MPH Stock Forecast, Price & News

C$1.15
+0.04 (+3.60%)
(As of 11/30/2022 05:20 PM ET)
Add
Compare
Today's Range
C$1.15
C$1.15
50-Day Range
C$0.96
C$1.15
52-Week Range
C$0.80
C$1.50
Volume
100 shs
Average Volume
5,310 shs
Market Capitalization
C$11.79 million
P/E Ratio
12.78
Dividend Yield
N/A
Price Target
N/A

About Medicure

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MPH Stock News Headlines

MEDICURE ANNOUNCES RESULTS OF 2022 AGM
Priyanka Chopra announces new project happening this month
Gland Pharma Ltd
Medicure Announces Normal Course Issuer Bid
Why Medicure Inc.'s (CVE:MPH) CEO Pay Matters To You
Medicure Q2 2019 Results and Conference Call Dates
Medicure Inc. (MPH.V)
See More Headlines
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MPH Company Calendar

Last Earnings
5/24/2017
Today
12/01/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$23.19 million
Cash Flow
C$0.49 per share
Book Value
C$1.81 per share

Miscellaneous

Free Float
N/A
Market Cap
C$11.79 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Albert David Friesen Ph.D. (Age 75)
    Founder, CEO & Chairman of the board
    Comp: $302.06k
  • Dr. Neil Owens Ph.D.
    Pres & COO
  • Mr. Haaris Uddin B.Com.
    CPA, Chief Financial Officer
  • Dr. Reuben Saba Ph.D.
    VP of Scientific & Medical Affairs
  • Ms. Jamie Gowryluk
    VP of Commercial Operations













MPH Stock - Frequently Asked Questions

How have MPH shares performed in 2022?

Medicure's stock was trading at C$0.92 on January 1st, 2022. Since then, MPH stock has increased by 25.0% and is now trading at C$1.15.
View the best growth stocks for 2022 here
.

How were Medicure's earnings last quarter?

Medicure Inc. (CVE:MPH) released its quarterly earnings data on Wednesday, May, 24th. The company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of $0.04 by $0.37. The business had revenue of $8.71 million for the quarter, compared to the consensus estimate of $14.50 million.

What other stocks do shareholders of Medicure own?
What is Medicure's stock symbol?

Medicure trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MPH."

How do I buy shares of Medicure?

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Medicure's stock price today?

One share of MPH stock can currently be purchased for approximately C$1.15.

How much money does Medicure make?

Medicure (CVE:MPH) has a market capitalization of C$11.79 million and generates C$23.19 million in revenue each year.

How can I contact Medicure?

Medicure's mailing address is 1250 Waverley St Suite 2, WINNIPEG, MB R3T 6C6, Canada. The official website for the company is www.medicure.com. The company can be reached via phone at +1-204-4877412.

This page (CVE:MPH) was last updated on 12/1/2022 by MarketBeat.com Staff